PHIN:NYSEPHINIA Inc. Analysis
Data as of 2026-09-05 - not real-time
$69.04
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
PHINIA Inc. is priced at $69.04, and its moving averages give no clean directional read — the structure is neutral. Across the trailing 30 sessions it lost 11.9%. Momentum indicators put RSI at 39.8 (approaching oversold) with MACD reading bearish. Watch $66.48 as support and $75.88 as the nearer resistance level.
Valuation screens as undervalued, on a P/E of 19.6 with no clean sector comparison available. Analyst price targets sit 36.2% above the current price. Revenue is growing at 5.6% on a 3.7% profit margin. The 1.75% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 46.4%, a beta of 1.01 and a maximum drawdown of 21.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
Valuation screens as undervalued, on a P/E of 19.6 with no clean sector comparison available. Analyst price targets sit 36.2% above the current price. Revenue is growing at 5.6% on a 3.7% profit margin. The 1.75% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 46.4%, a beta of 1.01 and a maximum drawdown of 21.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
Top Market Events
AUBURN HILLS, Mich. AP — AUBURN HILLS, Mich. AP — Phinia Inc. PHIN on Thursday reported net income of $40 million...PHINIA's free cash flow surged 236% to $74 million despite a razor-thin EPS miss, as the fuel systems supplier beat on...PHINIA PHIN drew fresh attention after reporting second quarter 2026 earnings, issuing refined full year guidance, and...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 71.25
- MACD momentum is negative
- 30-day price change of -11.9%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 71.25
- Analyst targets imply +36.2% versus the current price
- 30-day volatility of 46.4%
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Analyst targets imply +36.2% versus the current price
- P/E ratio of 19.6
- 30-day volatility of 46.4%
Key Metrics & Analysis
Financial Health
Revenue Growth5.60%
Profit Margin3.73%
P/E Ratio19.6
ROE8.52%
ROA5.24%
Debt/Equity68.92
P/B Ratio1.6
Op. Cash Flow$359.0M
Free Cash Flow$269.2M
Technical Analysis
TrendNeutral
RSI39.8
Support$66.48
Resistance$75.88
MA 20$71.32
MA 50$75.63
MA 200$71.25
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48
Valuation
Fair Value$99.25
Target Price$94.00
Upside/Downside36.15%
GradeUndervalued
TypeBlend
Dividend Yield1.75%
Risk Assessment
Beta1.01
Volatility46.38%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.